ArticleAsia-Pacific journal of oncology nursing2025
Symptom cluster in patients with resected pancreatic cancer during adjuvant chemotherapy: A cross-sectional study.
Article in Asia-Pacific journal of oncology nursing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to characterize symptom profiles and identify symptom clusters based on the dimensions of occurrence, severity, and distress in postoperative patients with pancreatic cancer undergoing adjuvant chemotherapy. Methods: This cross-sectional study recruited postoperative patients with pancreatic cancer undergoing adjuvant chemotherapy at a tertiary hospital in Jiangsu Province, China, between January and March 2025. Baseline demographic and clinical data were collected one day before the chemotherapy initiation. Nutritional status was assessed using the Nutritional Risk Screening 2002 (NRS-2002). On Day 7 after the chemotherapy initiation, symptom burden and functional status were assessed using the Memorial Symptom Assessment Scale (MSAS) and the Karnofsky Performance Status (KPS) scale, respectively. Symptom clusters were identified through exploratory factor analysis (EFA), and performed separately for each dimension (occurrence, severity, and distress). Results: A total of 194 patients with a mean of 15.01 ± 4.50 symptoms were included in the final analysis. The most prevalent symptom was "Feeling drowsy" (85.8%), while "Feeling nervous" exhibited the highest severity (2.10 ± 1.54) and distress (2.10 ± 1.56) scores. Five symptom clusters were consistently identified among the three assessment dimensions (occurrence, severity, and distress): gastrointestinal, psychological, neuromuscular, physiological fatigue depletion, and body image disturbance. The inter-dimensional consistency rates for these clusters were 86%, 80%, 75%, 60%, and 67%, respectively. Conclusions: This study demonstrates that postoperative patients with pancreatic cancer undergoing adjuvant chemotherapy experience a significant multidimensional symptom burden. Three symptom clusters (gastrointestinal, psychological, neuromuscular) showed high inter-dimensional consistency (≥ 75%), warranting prioritized intervention. Lower-consistency clusters (physiological energy depletion, body image disturbance) require multidimensional assessment for precise management. Three-dimensional assessment can improve personalized care and optimizes patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.